Of a solid-phase random peptide library to identify inhibitors of TNF-alpha mediated cytotoxicity in vitro

被引:15
作者
ChirinosRojas, CL [1 ]
Steward, MW [1 ]
Partidos, CD [1 ]
机构
[1] UNIV LONDON LONDON SCH HYG & TROP MED,DEPT CLIN SCI,MOL IMMUNOL UNIT,LONDON WC1E 7HT,ENGLAND
关键词
cytokines; cytotoxicity; peptide libraries; tumour necrosis factor; tumour necrosis factor receptor;
D O I
10.1006/cyto.1996.0158
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tumour necrosis factor (TNF) is a pleiotropic cytokine which plays a central role in infection, inflammation and autoimmune diseases, Its functions are mediated through binding to high affinity cell surface receptors, An approach to modulate excessive levels of TNF-alpha in the serum is the use of soluble receptors, In this study the potential of a solid-phase combinatorial peptide library was investigated to identify peptide mimics of the binding site of the TNF-alpha receptor, One of the identified mimotopes was shown to inhibit TNF-alpha-mediated cytotoxicity in mouse L929 and in a human KYM-1D4 cell lines in a dose-dependent fashion, Characterization of the mimotope sequence by high-performance liquid chromatography and mass spectroscopy has shown that the inhibitory effect of the mimotope was dependent upon the presence of a protective MTR group on the side chains of the arginine residues in the mimotope sequence, Furthermore, antibodies to the mimotope were shown to recognize the remombinant human TNF 55-kDa receptor in an ELISA assay, These findings highlight the potential of combinatorial peptide libraries in identifying peptide mimics of the binding site of TNF-alpha receptor, which can be used as competive inhibitors of ligand-receptor interactions. (C) 1997 Academic Press Limited.
引用
收藏
页码:226 / 232
页数:7
相关论文
共 29 条
  • [1] PROTECTION AGAINST ENDOTOXIC-SHOCK BY A TUMOR-NECROSIS-FACTOR RECEPTOR IMMUNOADHESIN
    ASHKENAZI, A
    MARSTERS, SA
    CAPON, DJ
    CHAMOW, SM
    FIGARI, IS
    PENNICA, D
    GOEDDEL, DV
    PALLADINO, MA
    SMITH, DH
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (23) : 10535 - 10539
  • [2] THE CYTOKINE NETWORK
    BALKWILL, FR
    BURKE, F
    [J]. IMMUNOLOGY TODAY, 1989, 10 (09): : 299 - 303
  • [3] CRYSTAL-STRUCTURE OF THE SOLUBLE HUMAN 55 KD TNF RECEPTOR-HUMAN TNF-BETA COMPLEX - IMPLICATIONS FOR TNF RECEPTOR ACTIVATION
    BANNER, DW
    DARCY, A
    JANES, W
    GENTZ, R
    SCHOENFELD, HJ
    BROGER, C
    LOETSCHER, H
    LESSLAUER, W
    [J]. CELL, 1993, 73 (03) : 431 - 445
  • [4] BEUTLER B, 1989, ANNU REV IMMUNOL, V7, P625, DOI 10.1146/annurev.iy.07.040189.003205
  • [5] TNF RECEPTOR FUSION PROTEINS ARE EFFECTIVE INHIBITORS OF TNF-MEDIATED CYTOTOXICITY ON HUMAN KYM-1D4 RHABDOMYOSARCOMA CELLS
    BUTLER, DM
    SCALLON, B
    MEAGER, A
    KISSONERGHIS, M
    CORCORAN, A
    CHERNAJOVSKY, Y
    FELDMANN, M
    GHRAYEB, J
    BRENNAN, FM
    [J]. CYTOKINE, 1994, 6 (06) : 616 - 623
  • [6] DEMBIC Z, 1990, Cytokine, V2, P231, DOI 10.1016/1043-4666(90)90022-L
  • [7] RANDOM PEPTIDE LIBRARIES - A SOURCE OF SPECIFIC PROTEIN-BINDING MOLECULES
    DEVLIN, JJ
    PANGANIBAN, LC
    DEVLIN, PE
    [J]. SCIENCE, 1990, 249 (4967) : 404 - 406
  • [8] ENGELMANN H, 1989, J BIOL CHEM, V264, P11974
  • [9] ENGELMANN H, 1990, J BIOL CHEM, V265, P1531
  • [10] FOXWELL B, 1990, CLIN EXP IMMUNOL, V90, P161